Correlation Between BioAffinity Technologies and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between bioAffinity Technologies Warrant and Champions Oncology, you can compare the effects of market volatilities on BioAffinity Technologies and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies and Champions Oncology.
Diversification Opportunities for BioAffinity Technologies and Champions Oncology
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between BioAffinity and Champions is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies Warra and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and BioAffinity Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies Warrant are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of BioAffinity Technologies i.e., BioAffinity Technologies and Champions Oncology go up and down completely randomly.
Pair Corralation between BioAffinity Technologies and Champions Oncology
Assuming the 90 days horizon BioAffinity Technologies is expected to generate 17.6 times less return on investment than Champions Oncology. In addition to that, BioAffinity Technologies is 2.95 times more volatile than Champions Oncology. It trades about 0.0 of its total potential returns per unit of risk. Champions Oncology is currently generating about 0.19 per unit of volatility. If you would invest 471.00 in Champions Oncology on October 24, 2024 and sell it today you would earn a total of 507.00 from holding Champions Oncology or generate 107.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 88.89% |
| Values | Daily Returns |
bioAffinity Technologies Warra vs. Champions Oncology
Performance |
| Timeline |
| BioAffinity Technologies |
| Champions Oncology |
BioAffinity Technologies and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioAffinity Technologies and Champions Oncology
The main advantage of trading using opposite BioAffinity Technologies and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| BioAffinity Technologies vs. Nuvalent | BioAffinity Technologies vs. Arcellx | BioAffinity Technologies vs. Vaxcyte | BioAffinity Technologies vs. Crinetics Pharmaceuticals |
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |